Cristina Muñoz-García

Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment

N. Bargalló, B. Bosch, L. Rami, 2019, NeuroImage: Clinical.

CSF microRNA Profiling in Alzheimer’s Disease: a Screening and Validation Study

J. Molinuevo, A. Lleó, L. Rami, 2017, Molecular Neurobiology.

Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants

L. Armengol, B. Rodríguez-Santiago, B. Bosch, 2020, Neurobiology of Aging.

Altered Blood Gene Expression of Tumor-Related Genes (PRKCB, BECN1, and CDKN2A) in Alzheimer’s Disease

J. Molinuevo, P. Boya, S. Kalko, 2015, Molecular Neurobiology.

1 Altered blood gene expression of tumor-related genes ( PRKCB , BECN 1 and CDKN 2 A ) in Alzheimer ’ s disease

J. Molinuevo, P. Boya, S. Kalko, 2015 .

Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias

K. Blennow, J. Molinuevo, B. Bosch, 2019, Alzheimer's & Dementia.